Relationship between Lymphokine and Opiatergic Modulation of Lymphocyte Proliferation

  • William L. Farrar


T lymphocytes are primary effector cells of cell-mediated immunity as well as regulators of growth (clonal expansion) and differentiation of the immune system. Until less than a decade ago, their regulatory activity was presumed to be attributed to predominantly cellular interactions mediated by membrane-bound recognitive elements often associated with the major histocompatibility (H2 or HLA) complex. Recently, in the historical context of the development of immunological models, many regulatory functions of T lymphocytes appear to be mediated by molecules secreted by various functionally distinct subpopulations of lymphoid and nonlymphoid cells. Indeed, the principle regulatory cells of the immune system, T lymphocytes, are also under the regulatory influence of specific monocyte/ macrophage derived cytokines referred to as monokines. In addition to regulating lymphocyte activities, there is considerable evidence that lymphocyte-derived molecules, lymphokines, influence the differentiation of hematopoietic cells, mast cells, fibroblasts, and osteoclasts1–6. This suggests that the regulatory cytokines produced by specific antigen may also effect hematopoietic homeostasis as well as inflammatory cells involved in immediate hypersensitivities. Lymphokines are considered to be actively synthesized (transcription of DNA) and secreted by either native lymphoid cells or their malignant cell line counterparts (macrophage or lymphocyte). While normal lymphoid tissues or cells must be activated by antigen or polyclonal stimulation to produce lymphokines, some longterm cell lines have been fortuitously shown to constitutively secrete lymphokines. Indeed, such cell lines have been critical for providing the genetic library for the recombinant DNA cloning of several lymphokines. Lymphokines provide nonspecific augmentation to antigen-specific responses. Lymphokines can generally be readily separated by conventional biochemical chromatography, but standard 280 nm absorbance and protein stains have been of little value since they are usually present in culture media in nanomolar concentrations. Finally, with the introduction of monoclonal antibodies, several lymphokines may be neutralized and quantitated in vitro by specific antibody.


Natural Killer Peripheral Blood Lymphocyte Proliferative Response Adenylate Cyclase Activity Opiate Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. W. Ruscetti, R. H. Cypess, and P. S. Chervenick, Blood 47: 757 (1976).Google Scholar
  2. 2.
    J. J. Oppenheim and I. Gery, Immunology Today 3: 113 (1982).CrossRefGoogle Scholar
  3. K. Tadokoro, B. M. Stadler and A. L. DeWeck, J. Exp. Med. 158:857 (1983).Google Scholar
  4. 4.
    J. W. Adamson, W. J. Dopovic and J. E. Brown, in: “Hematopoitetic Cell Differentiation,” D. W. Golde, M. J. Cline, D. Metcalf, C. F. Fox, eds., Academic Press, New York (1978).Google Scholar
  5. 5.
    A. W. Burgess, D. Metcalf, N. A. Nicola and S.H.M. Russel, in: “Hematopoietic Cell Differentiation,” D. W. Golde, M. J. Cline, D. Metcalf, C. F. Fox, eds., Academic Press, New York (1978).Google Scholar
  6. 6.
    Y. P. Yung, R. Eger, G. Tertian and M.A.S. Moore, J. Immunol. 127: 794 (1981).Google Scholar
  7. J. J. Farrar and J. Fuller-Bonar, J. Immunol. 117:274 (1976).Google Scholar
  8. J. J. Farrar, W. J. Koopman and J. Fuller-Bonar, J. Immunol. 114:47 (1977).Google Scholar
  9. 9.
    J. J. Farrar, P. L. Simon, W. J. Koopman and J. F. Bonar, J. Immunol. 121: 1353 (1978).Google Scholar
  10. 10.
    D. D. Wood, J. Immunol. 123: 2400 (1979).Google Scholar
  11. 11.
    W. L. Farrar, S. B. Mizel and J. J. Farrar, J. Immunol. 124: 1371 (1980).Google Scholar
  12. S. Gillis, P. E. Baker, F. W. Ruscetti and K. A. Smith, J. Exp. Med. 154:983 (1978).Google Scholar
  13. J. J. Farrar, W. R. Benjamin, M. L. Hilfker, M. Howard, W. L. Farrar and J. Fuller-Farrar, Immunol. Rev. 63:129 (1982).Google Scholar
  14. 14.
    R. W. Ruscetti, D. A. Morgan and R. C. Gallo, J. Immunol. 122: 2527 (1979).Google Scholar
  15. S. B. Mizel and D. L. Rosenstreich, J. Immunol. 122:2173 (1979).Google Scholar
  16. 16.
    J. J. Farrar, J. Fuller-Farrar, P. L. Simon, M. L. Hilfiker, B. M. Stadler and W. L. Farrar, J. Immunol. 125: 2555 (1980a).Google Scholar
  17. 17.
    J. J. Farrar, S. B. Mizel, J. Fuller-Bonar, M. L. Hllfiker and W. L. Farrar, Microbiol. 36: 39 (1980b).Google Scholar
  18. 18.
    K. A. Smith, L. B. Lachman, J. J. Oppenheim and M. F. Favata, J. Exp. Med. 151: 1551 (1980).PubMedCrossRefGoogle Scholar
  19. 19.
    E. L. Larsson, N. N. Iscove and A. Coutinho, Nature 283: 664 (1980).CrossRefGoogle Scholar
  20. 20.
    R. N. Moore, J. J. Oppenheim, J. J. Farrar, C. S. Carter, A. Waheed and R. K. Shadduck, J. Immunol. 3: 119 (1980).Google Scholar
  21. 21.
    R. N. Moore, J. T. Haffeld, J. J. Farrar, S. E. Mergenhagen, J. J. Oppenheim and R. K. Shadduck, Lymphokines 3: 119 (1981).Google Scholar
  22. 22.
    W. L. Farrar, H. M. Johnson and J. J. Farrar, J. Immunol. 126: 1120 (1981).Google Scholar
  23. 23.
    C. S. Henney, K. Kuribaysashi, D. E. Kern and S. Gillis, Nature 291: 335 (1981).Google Scholar
  24. W. Domzig, B. M. Stadler and R. B. Herberman, J. Immunol. 130:1970 (1983).Google Scholar
  25. D. A. Weignet, G. J. Stanton and H. M. Johnson, Infect. Immun. 41:992 (1983).Google Scholar
  26. H. M. Johnson and W. L. Farrar, Cell. Immunol. 75:154 (1983).Google Scholar
  27. P. S. Steeg, R. N. Moore, H. M. Johnson and J. J. Oppenheim, J. Exp. Med. 156:1780 (1983).Google Scholar
  28. 28.
    T. Y. Basham and T. C. Merigan, J. Immunol. 130: 1492 (1983).Google Scholar
  29. 29.
    B. Harfest, J. R. Huddleston, P. Casali, T. C. Merigun and M.B.A. Olstone, J. Immunol. 127: 2146 (1981).Google Scholar
  30. 30.
    D. N. Mannel and W. Falk, Cell. Immunol. 79: 396 (1983).CrossRefGoogle Scholar
  31. J. R. Ortaldo, A. Mantovani, D. Hobbs, M. Rubinstein, S. Pestica and R. B. Herberman, Int. J. Cancer 31:285 (1983).Google Scholar
  32. M. C. Howard, J. Farrar, M. Hilfiker, B. Johnson, T. Takatsu and W. L. Paul, J. Exp. Med. 155:914 (1982).Google Scholar
  33. 33.
    A. Schimpl and W. Wicker, Nature 237: 15 (1972).Google Scholar
  34. 34.
    T. Kasahara, J. Y. Djeu, S. F. Dougherty and J. J. Oppenheim, J. Immunol. 131: 2379 (1983).PubMedGoogle Scholar
  35. 35.
    A. Hapel, J. C. Lee, W. L. Farrar and J. W. Ihle, Cell 25: 179 (1981).CrossRefGoogle Scholar
  36. J. W. Schrader and I. Clark-Lewis, J. Immunol. 129:30 (1982).Google Scholar
  37. 37.
    E. Hazum, K-J. Chang and P. Cuatrecasas, Science 205: 1033 (1979).CrossRefGoogle Scholar
  38. 38.
    S. C. Gilman, J. M. Schwartz, R. J. Milner, F. E. Bloom and J. D. Feldman, PNAS 79: 4226 (1982).CrossRefGoogle Scholar
  39. P. M. Mathews, C. J. Froelich, W. L. Sibbitt and A. D. Bankhurst, J. Immunol. 130:1658 (1983).Google Scholar
  40. 40.
    Y. Yamasaki, K. Shimamura, A. Kizu, M. Nakagawa and H. Ijichi, Life Sciences 31: 471 (1982).CrossRefGoogle Scholar
  41. 41.
    H.O.J. Cailler and A. C. Roy, Nature 248: 24 (1974).CrossRefGoogle Scholar
  42. 42.
    R. S. Childers, S. M. Lambert and G. LaRiviere, Life Sciences 33: 215 (1983).CrossRefGoogle Scholar
  43. 43.
    R. D. Maca, Immunopharmacol. 6: 267 (1983).CrossRefGoogle Scholar
  44. P. E. Baker, J. V. Fahey and A. Munck, J. Exp. Med. 61:52 (1981).Google Scholar
  45. P. N. Shek and B. H. Sabiston, Int. J. Immunopharmacol. 5:23 (1983).Google Scholar
  46. 46.
    C. I. Thompson, J. W. Kreider, P. L. Black, T. J. Schmidt and D. L. Margules, Science 220: 1183 (1983).Google Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • William L. Farrar
    • 1
  1. 1.Laboratory of Molecular Immunoregulation, Biological Response Modifiers ProgramNational Cancer Institute-FCRFFrederickUSA

Personalised recommendations